checkAd
    Startseite > Aktien > BetterLife Pharma > Nachrichten
    BetterLife Pharma Aktie
    0,1250
     
    CAD
    +4,17 %
    +0,0050 CAD
    Letzter Kurs 10.05.24 CSE
    0,1150
     
    CAD
    31.500 STK
    Geldkurs 10.05.24
    0,1300
     
    CAD
    91.500 STK
    Briefkurs 10.05.24
    ISIN: CA08772P2026 · WKN: A2P7XN · SYM: BETR · Kanada

    Neueste Nachrichten

    BetterLife Announces Intent to Complete Private Placement of Units
    04.05.24 · globenewswire · BetterLife Pharma
    BetterLife Advances BETR-001 IND-enabling Studies
    01.05.24 · globenewswire · BetterLife Pharma
    BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
    11.04.24 · globenewswire · BetterLife Pharma
    BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
    03.04.24 · globenewswire · BetterLife Pharma
    BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University
    04.03.24 · globenewswire · BetterLife Pharma
    BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
    02.01.24 · globenewswire · BetterLife Pharma
    BetterLife Announces Closing of a Private Placement
    18.12.23 · globenewswire · BetterLife Pharma
    BetterLife Announces Extension of Warrants
    30.11.23 · globenewswire · BetterLife Pharma
    US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives
    15.11.23 · globenewswire · BetterLife Pharma
    BetterLife Pharma to Host Investors Update Call on September 18, 2023
    14.09.23 · globenewswire · BetterLife Pharma
    BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001
    12.09.23 · globenewswire · BetterLife Pharma
    BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement
    05.09.23 · globenewswire · BetterLife Pharma